Tencent and others invest in Xinjing Zhiyuan Biotechnology Company

According to the Tianyancha App, recently, there have been changes in the business registration of Xingjing Zhiyuan Biotechnology Co., Ltd., with the addition of Guangxi Tencent Entrepreneurial Investment Co., Ltd. and Wenzhou Tonggao Chuangyue Entrepreneurial Investment Partnership Enterprise as shareholders. At the same time, the registered capital has increased from approximately 6.2807 million RMB to about 7.7922 million RMB. The company was established in September 2020, with Peng Songming as the legal representative. Its business scope includes pharmaceutical production, medical research, and experimental development. Currently, Peng Songming, Guangzhou Baidu Venture Capital Artificial Intelligence Equity Investment Partnership Enterprise, and the aforementioned new shareholders collectively hold shares in the company. The official website shows that the company is an innovative company focused on developing TCR-T immunocellular therapy drugs for solid tumors, researching clinical technologies, and transformation.